Document_and_Entity_Informatio
Document and Entity Information | 3 Months Ended | |
Jul. 27, 2014 | Aug. 29, 2014 | |
Document and Entity Information [Abstract] | ' | ' |
Entity Registrant Name | 'FINISAR CORP | ' |
Entity Central Index Key | '0001094739 | ' |
Current Fiscal Year End Date | '--05-03 | ' |
Entity Filer Category | 'Large Accelerated Filer | ' |
Document Type | '10-Q | ' |
Document Period End Date | 27-Jul-14 | ' |
Document Fiscal Year Focus | '2015 | ' |
Document Fiscal Period Focus | 'Q1 | ' |
Amendment Flag | 'false | ' |
Entity Common Stock, Shares Outstanding | ' | 99,556,756 |
Condensed_Consolidated_Balance
Condensed Consolidated Balance Sheets (USD $) | Jul. 27, 2014 | Apr. 27, 2014 |
In Thousands, unless otherwise specified | ||
Current assets: | ' | ' |
Cash and cash equivalents | $287,455 | $303,101 |
Short-term investments | 209,927 | 209,922 |
Accounts receivable, net of allowance for doubtful accounts of $806 at July 27, 2014 and $929 at April 27, 2014 | 231,312 | 225,020 |
Accounts receivable, other | 41,595 | 33,749 |
Inventories | 270,122 | 259,759 |
Prepaid expenses and other current assets | 38,582 | 33,022 |
Total current assets | 1,078,993 | 1,064,573 |
Property, equipment and improvements, net | 301,020 | 273,328 |
Purchased intangible assets, net | 33,680 | 34,140 |
Goodwill | 106,735 | 106,114 |
Minority investments | 2,317 | 2,117 |
Other assets | 20,907 | 17,274 |
Total assets | 1,543,652 | 1,497,546 |
Current liabilities: | ' | ' |
Accounts payable | 143,224 | 119,439 |
Accrued compensation | 28,215 | 38,541 |
Other accrued liabilities | 27,815 | 31,776 |
Deferred revenue | 16,872 | 16,659 |
Current portion of convertible debt | 40,015 | 40,015 |
Total current liabilities | 256,141 | 246,430 |
Long-term liabilities: | ' | ' |
Current portion of convertible debt | 214,496 | 212,253 |
Other non-current liabilities | 24,042 | 22,804 |
Total liabilities | 494,679 | 481,487 |
Commitments and contingencies | ' | ' |
Stockholders' equity: | ' | ' |
Preferred stock, $0.001 par value, 5,000,000 shares authorized, no shares issued and outstanding at July 27, 2014 and April 28, 2014 | 0 | 0 |
Common stock, $0.001 par value, 750,000,000 shares authorized 99,528,871 shares and 97,281,665 shares issued and outstanding at July 27, 2014 and April 28, 2014, respectively | 100 | 97 |
Additional paid-in capital | 2,469,687 | 2,456,110 |
Accumulated other comprehensive income | 25,116 | 20,025 |
Accumulated deficit | -1,445,930 | -1,460,173 |
Total stockholders' equity | 1,048,973 | 1,016,059 |
Total liabilities and stockholders' equity | $1,543,652 | $1,497,546 |
Condensed_Consolidated_Balance1
Condensed Consolidated Balance Sheets Parenthetical (USD $) | Jul. 27, 2014 | Apr. 27, 2014 |
In Thousands, except Share data, unless otherwise specified | ||
Statement of Financial Position [Abstract] | ' | ' |
Allowance for doubtful accounts | $806 | $929 |
Preferred stock, par value | $0.00 | $0.00 |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value | $0.00 | $0.00 |
Common stock, shares authorized | 750,000,000 | 750,000,000 |
Common stock, shares issued | 99,528,871 | 97,281,665 |
Common stock, shares outstanding | 99,528,871 | 97,281,665 |
Condensed_Consolidated_Stateme
Condensed Consolidated Statements of Operations (Unaudited) (USD $) | 3 Months Ended | |
In Thousands, except Per Share data, unless otherwise specified | Jul. 27, 2014 | Jul. 28, 2013 |
Income Statement [Abstract] | ' | ' |
Revenues | $327,638 | $266,068 |
Cost of revenues | 227,384 | 173,102 |
Amortization of acquired developed technology | 1,435 | 1,593 |
Gross profit | 98,819 | 91,373 |
Operating expenses: | ' | ' |
Research and development | 51,007 | 43,530 |
Sales and marketing | 11,965 | 11,805 |
General and administrative | 14,719 | 8,340 |
Amortization of purchased intangibles | 761 | 595 |
Total operating expenses | 78,452 | 64,270 |
Income from operations | 20,367 | 27,103 |
Interest income | 612 | 217 |
Interest expense | -3,133 | -552 |
Other income (expense), net | -2,026 | 488 |
Income before income taxes and non-controlling interest | 15,820 | 27,256 |
Provision for income taxes | 1,577 | 1,421 |
Consolidated net income | 14,243 | 25,835 |
Adjust for net loss attributable to non-controlling interest | 0 | 176 |
Net income attributable to Finisar Corporation | $14,243 | $26,011 |
Net income per share attributable to Finisar Corporation common stockholders: | ' | ' |
Basic (in dollars per share) | $0.14 | $0.27 |
Diluted (in dollars per share) | $0.14 | $0.26 |
Shares used in computing net income per share: | ' | ' |
Basic (in shares) | 98,241 | 94,609 |
Diluted (in shares) | 102,287 | 101,125 |
Condensed_Consolidated_Stateme1
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Jul. 27, 2014 | Jul. 28, 2013 |
Statement of Comprehensive Income [Abstract] | ' | ' |
Consolidated net income | $14,243 | $25,835 |
Other comprehensive income (loss), net of tax: | ' | ' |
Change in cumulative foreign currency translation adjustment | 5,091 | -6,128 |
Total other comprehensive income (loss), net of tax | 5,091 | -6,128 |
Total consolidated comprehensive income | 19,334 | 19,707 |
Adjust for comprehensive loss attributable to non-controlling interest, net of tax | 0 | 176 |
Comprehensive income attributable to Finisar Corporation | $19,334 | $19,883 |
Condensed_Consolidated_Stateme2
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Jul. 27, 2014 | Jul. 28, 2013 |
Operating activities | ' | ' |
Consolidated net income | $14,243 | $25,835 |
Adjustments to reconcile consolidated net income to net cash provided by operating activities: | ' | ' |
Depreciation | 19,648 | 13,970 |
Amortization of intangible assets | 2,195 | 2,188 |
Amortization of debt issuance costs | 193 | 39 |
Stock-based compensation expense | 11,053 | 8,909 |
Loss (gain) on sale or retirement of assets and asset disposal group | 650 | -103 |
Equity in earnings of equity method investment | -200 | -179 |
Amortization of discount on 0.50% Convertible Senior Notes due 2033 | 2,243 | 0 |
Changes in operating assets and liabilities: | ' | ' |
Accounts receivable | -5,840 | -24,286 |
Inventories | -6,787 | -12,459 |
Other assets | -17,837 | -17,245 |
Deferred income taxes | 0 | 240 |
Accounts payable | 23,738 | 13,979 |
Accrued compensation | -14,165 | -1,051 |
Other accrued liabilities | -2,840 | 7,987 |
Deferred revenue | -280 | 2,907 |
Net cash provided by operating activities | 26,014 | 20,731 |
Investing activities | ' | ' |
Additions to property, equipment and improvements | -45,076 | -27,874 |
Net proceeds from sale of property and equipment and asset disposal group | 0 | 408 |
Purchases of short-term investments | -59,949 | 0 |
Maturities of short-term investments | 60,000 | 0 |
Acquisition, net of cash acquired | -2,728 | 0 |
Net cash used in investing activities | -47,753 | -27,466 |
Financing activities | ' | ' |
Repayments of term loans | -71 | 0 |
Proceeds from the issuance of shares under equity plans and employee stock purchase plan | 6,164 | 6,092 |
Net cash provided by financing activities | 6,093 | 6,092 |
Net decrease in cash and cash equivalents | -15,646 | -643 |
Cash and cash equivalents at beginning of period | 303,101 | 289,076 |
Cash and cash equivalents at end of period | 287,455 | 288,433 |
Supplemental disclosure of cash flow information | ' | ' |
Cash paid for interest | 643 | 0 |
Cash paid for taxes | $2,637 | $851 |
Basis_of_Presentation
Basis of Presentation | 3 Months Ended |
Jul. 27, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Basis of Presentation | ' |
Basis of Presentation | |
The accompanying unaudited condensed consolidated financial statements as of July 27, 2014 and for the three month periods ended July 27, 2014 and July 28, 2013 have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial statements and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”), and include the accounts of Finisar Corporation and its controlled subsidiaries (collectively, “Finisar” or the “Company”). Non-controlling interest represents the minority shareholders' proportionate share of the net assets and results of operations of the Company's majority-owned subsidiary, Finisar Korea, prior to its sale in the fourth quarter of fiscal 2014. Intercompany accounts and transactions have been eliminated in consolidation. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP and pursuant to the rules and regulations of the SEC have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of the Company's financial position as of July 27, 2014, its operating results for the three month periods ended July 27, 2014 and July 28, 2013, and its cash flows for the three month periods ended July 27, 2014 and July 28, 2013. Operating results for the three month periods ended July 27, 2014 are not necessarily indicative of the results that may be expected for the fiscal year ending May 3, 2015. The condensed consolidated balance sheet as of April 27, 2014 has been derived from the audited consolidated financial statements as of that date but does not include all the footnotes required by U.S. GAAP for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the fiscal year ended April 27, 2014. | |
Use of Estimates | |
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates. | |
Segments | |
The Company has one reportable segment consisting of optical subsystems and components. |
Summary_of_Significant_Account
Summary of Significant Accounting Policies | 3 Months Ended |
Jul. 27, 2014 | |
Accounting Policies [Abstract] | ' |
Summary of Significant Accounting Policies | ' |
Summary of Significant Accounting Policies | |
For a description of significant accounting policies, see Note 2, Summary of Significant Accounting Policies, to the consolidated financial statements included in the Company's annual report on Form 10-K for the fiscal year ended April 27, 2014. There have been no material changes to the Company's significant accounting policies since the filing of the annual report on Form 10-K. | |
Pending Adoption of New Accounting Standards | |
From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board ("FASB") or other standards setting bodies that are adopted by the Company as of the specified effective date. The Company believes the impact of recently issued standards that are not yet effective will not have a material impact on its consolidated financial position, results of operations and cash flows upon adoption. |
Net_Income_per_Share
Net Income per Share | 3 Months Ended | |||||||
Jul. 27, 2014 | ||||||||
Earnings Per Share [Abstract] | ' | |||||||
Net Income per Share | ' | |||||||
Net Income per Share | ||||||||
Basic net income per share has been computed using the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share has been computed using the weighted-average number of shares of common stock and dilutive potential common shares from stock options and restricted stock units (under the treasury stock method), 5.0% Convertible Senior Notes due 2029 (on an as-if-converted basis), and 0.50% Convertible Senior Notes due 2033 (under the treasury stock method) outstanding during the period. | ||||||||
The following table presents the calculation of basic and diluted net income per share: | ||||||||
Three Months Ended | ||||||||
(in thousands, except per share amounts) | July 27, 2014 | July 28, 2013 | ||||||
Numerator: | ||||||||
Net income attributable to Finisar Corporation | $ | 14,243 | $ | 26,011 | ||||
Numerator for basic net income per share | 14,243 | 26,011 | ||||||
Effect of dilutive securities: | ||||||||
Interest expense on 5.0% Convertible Senior Notes due 2029 | — | 539 | ||||||
Numerator for diluted net income per share | $ | 14,243 | $ | 26,550 | ||||
Denominator: | ||||||||
Denominator for basic net income per share - weighted average shares | 98,241 | 94,609 | ||||||
Effect of dilutive securities: | ||||||||
Stock options and restricted stock units | 4,046 | 2,768 | ||||||
5.0% Convertible Senior Notes due 2029 | — | 3,748 | ||||||
Dilutive potential common shares | 4,046 | 6,516 | ||||||
Denominator for diluted net income per share | 102,287 | 101,125 | ||||||
Net income per share attributable to Finisar Corporation common stockholders: | ||||||||
Basic | $ | 0.14 | $ | 0.27 | ||||
Diluted | $ | 0.14 | $ | 0.26 | ||||
The following table presents common shares related to potentially dilutive securities excluded from the calculation of diluted net income per share as their effect would have been anti-dilutive: | ||||||||
Three Months Ended | ||||||||
(in thousands) | July 27, 2014 | July 28, 2013 | ||||||
Stock options and restricted stock units | 627 | 2,537 | ||||||
5.0% Convertible Senior Notes due 2029 | 3,748 | — | ||||||
0.50% Convertible Senior Notes due 2033 (1) | — | — | ||||||
4,375 | 2,537 | |||||||
_______________ | ||||||||
(1) 0.50% Convertible Senior Notes due 2033 were excluded from the calculation of diluted earnings per share under the treasury stock method since the conversion price exceeded the average market price for the Company's common stock. |
Inventories
Inventories | 3 Months Ended | |||||||
Jul. 27, 2014 | ||||||||
Inventory Disclosure [Abstract] | ' | |||||||
Inventories | ' | |||||||
Inventories | ||||||||
Inventories consist of the following: | As of | |||||||
(in thousands) | July 27, 2014 | April 27, 2014 | ||||||
Raw materials | $ | 56,858 | $ | 52,594 | ||||
Work-in-process | 126,899 | 126,181 | ||||||
Finished goods | 86,365 | 80,984 | ||||||
Total inventories | $ | 270,122 | $ | 259,759 | ||||
Investments
Investments | 3 Months Ended | |||||||||||||||||||||||||
Jul. 27, 2014 | ||||||||||||||||||||||||||
Investments [Abstract] | ' | |||||||||||||||||||||||||
Investment | ' | |||||||||||||||||||||||||
Investments | ||||||||||||||||||||||||||
Fixed Income Securities | ||||||||||||||||||||||||||
The Company's portfolio of fixed income securities consists of commercial paper notes and term bank certificates of deposit. All of the Company's investments in fixed income securities have original maturity (maturity at the purchase date) of less than 12 months. Investments with original maturities of three months or less are classified as cash equivalents. All of the Company's investments in fixed income securities are classified as held-to-maturity since the Company has the positive intent and ability to hold these investments until maturity. These investments are carried at amortized cost. | ||||||||||||||||||||||||||
The Company's investments in fixed income securities as of July 27, 2014 and April 27, 2014 were as follows: | ||||||||||||||||||||||||||
July 27, 2014 | April 27, 2014 | |||||||||||||||||||||||||
Gross Unrealized | Gross Unrealized | |||||||||||||||||||||||||
(in thousands) | Amortized Cost | Gains | Losses | Fair Value | Amortized Cost | Gains | Losses | Fair Value | ||||||||||||||||||
Commercial paper | $ | 89,927 | $ | — | $ | — | $ | 89,927 | $ | 89,922 | $ | — | $ | — | $ | 89,922 | ||||||||||
Certificates of deposit | 120,000 | — | — | 120,000 | 120,000 | — | — | 120,000 | ||||||||||||||||||
Total | $ | 209,927 | $ | — | $ | — | $ | 209,927 | $ | 209,922 | $ | — | $ | — | $ | 209,922 | ||||||||||
Reported as: | ||||||||||||||||||||||||||
Short-term investments | $ | 209,927 | $ | — | $ | — | $ | 209,927 | $ | 209,922 | $ | — | $ | — | $ | 209,922 | ||||||||||
Total | $ | 209,927 | $ | — | $ | — | $ | 209,927 | $ | 209,922 | $ | — | $ | — | $ | 209,922 | ||||||||||
The Company monitors its investment portfolio for impairment on a periodic basis. In order to determine whether a decline in fair value is other-than-temporary, the Company evaluates, among other factors: the duration and extent to which the fair value has been less than the carrying value; the Company's financial condition and business outlook, including key operational and cash flow metrics, current market conditions and future trends in its industry; the Company's relative competitive position within the industry; and the Company's intent and ability to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value. A decline in the fair value of the security below amortized cost that is deemed other-than-temporary is charged to earnings, resulting in the establishment of a new cost basis for the affected securities. During the three month periods ended July 27, 2014 and July 28, 2013 there were no realized gains or losses, and the Company did not recognize any other-than-temporary impairments. | ||||||||||||||||||||||||||
Minority Investments | ||||||||||||||||||||||||||
Included in minority investments at both July 27, 2014 and April 27, 2014 is $884,000 representing the carrying value of the Company's minority investment in one privately held company accounted for under the cost method. Additionally, included in minority investments is $1.4 million and $1.2 million at July 27, 2014 and April 27, 2014, respectively, representing the carrying value of the Company's minority investment in one privately held company accounted for under the equity method. At July 27, 2014, the Company had a 19.9% ownership interest in this company. For the three month periods ended July 27, 2014 and July 28, 2013, the Company recorded income of $200,000 and $179,000, respectively, representing its share of the net income of this minority investee, which was included in other income (expense), net in the accompanying condensed consolidated statements of operations. |
Debt
Debt | 3 Months Ended | |||
Jul. 27, 2014 | ||||
Debt Disclosure [Abstract] | ' | |||
Debt | ' | |||
Debt | ||||
0.50% Convertible Senior Notes Due 2033 | ||||
In December 2013, the Company issued and sold $258.8 million in aggregate principal amount of 0.50% Convertible Senior Notes due 2033 (the "2033 Notes") at par. The terms of the notes are governed by an indenture by and between the Company and Wells Fargo Bank, National Association, as Trustee. The notes will mature on December 15, 2033, unless earlier repurchased, redeemed or converted. The notes are senior unsecured and unsubordinated obligations of the Company, and are effectively subordinated to the Company's secured indebtedness and the indebtedness and other liabilities of the Company's subsidiaries. The notes bear interest at a rate of 0.5% per year, payable semi-annually in arrears on June 15 and December 15 each year. | ||||
Holders of the notes may convert their notes at their option prior to the close of business on the business day immediately preceding June 15, 2033 only under the following circumstances: (1) during any fiscal quarter commencing after the fiscal quarter ending on January 26, 2014 (and only during such fiscal quarter), if the last reported sale price of the Company's common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period ("measurement period"), in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's common stock and the applicable conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events. On or after June 15, 2033 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their notes at any time, regardless of whether any of the foregoing circumstances have occurred. The conversion rate will initially equal 33.1301 shares of common stock per $1,000 principal amount of notes (which is equivalent to an initial conversion price of approximately $30.18 per share of common stock), subject to adjustment. Upon conversion of a note, the Company will pay or deliver, as the case may be, either cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company's election, as provided in the indenture. If holders elect to convert their notes in connection with a "fundamental change" (as defined in the indenture) that occurs on or before December 22, 2018, the Company will, to the extent provided in the indenture, increase the conversion rate applicable to such notes ("make-whole feature"). | ||||
Holders will have the option to require the Company to redeem for cash any notes held by them in the event of a fundamental change at a purchase price equal to 100% of the principal amount of the notes plus accrued and unpaid interest to, but excluding, the redemption date. Holders also have the option to require the Company to redeem for cash any notes held by them on December 15, 2018, December 15, 2023 and December 15, 2028 at a redemption price equal to 100% of the principal amount of the notes plus accrued and unpaid interest to, but excluding, the redemption date. The Company may redeem the notes in whole or in part at any time on or after December 22, 2018 at 100% of the principal amount, plus accrued and unpaid interest to, but excluding, the redemption date. | ||||
The Company considered the features embedded in the notes, that is, the conversion feature, the holders' put feature, the Company's call feature, and the make-whole feature, and concluded that they are not required to be bifurcated and accounted for separately from the host debt instrument. | ||||
Because of its option to settle conversion of the notes in cash, the Company separated the liability and equity components of the notes. The carrying amount of the liability component at issuance date of $209.1 million was calculated by estimating the fair value of similar liabilities without a conversion feature. The residual principal amount of the notes of $49.6 million was allocated to the equity component. The resulting debt discount is amortized as interest expense. As of July 27, 2014, the remaining debt discount amortization period was 52 months. | ||||
As of July 27, 2014, the notes consisted of the following (in thousands): | ||||
Liability component: | ||||
Principal | $ | 258,750 | ||
Unamortized debt discount | (44,254 | ) | ||
Net carrying amount of the liability component | $ | 214,496 | ||
Carrying amount of the equity component | $ | 49,648 | ||
The Company incurred approximately $3.8 million in transaction costs in connection with the issuance of the notes. These costs were allocated to the liability and equity components in proportion to the allocation of proceeds. Transaction costs of $3.1 million, allocated to the liability component, were recognized as a non-current asset and are amortized. Transaction costs of $725,000, allocated to the equity component, were recognized as a reduction of additional paid-in capital. | ||||
The following table sets forth interest expense information related to the 2033 Notes: | ||||
Three Months Ended | ||||
(in thousands, except percentages) | July 27, 2014 | |||
Contractual interest expense | $ | 323 | ||
Amortization of the debt discount | 2,243 | |||
Amortization of issuance costs | 154 | |||
Total interest cost | $ | 2,720 | ||
Effective interest rate on the liability component | 4.87 | % | ||
The Company applies the treasury stock method to determine the potential dilutive effect of the 2033 Notes on net income per share as a result of the Company's intent and stated policy to settle the principal amount of the Notes in cash. | ||||
5.0% Convertible Senior Notes Due 2029 | ||||
The terms of the Company's 5.0% Convertible Senior Notes due 2029 (the "2029 Notes") include a provision that allows the holders to require the Company to redeem, for cash, any of their notes on October 15, 2014 at a redemption price equal to 100% of the principal amount of the notes being redeemed, plus accrued and unpaid interest up to, but excluding, the redemption date. Accordingly, all $40.0 million of the 2029 Notes principal amount outstanding as of July 27, 2014 was classified as a current liability as of that date. |
Warranty
Warranty | 3 Months Ended | |||
Jul. 27, 2014 | ||||
Product Warranties Disclosures [Abstract] | ' | |||
Warranty | ' | |||
Warranty | ||||
The Company generally offers a one-year limited warranty for its products. The specific terms and conditions of these warranties vary depending upon the product sold. The Company estimates the costs that may be incurred under its basic limited warranty and records a liability for the amount of such costs at the time revenue is recognized. Factors that affect the Company's warranty liability include the historical and anticipated rates of warranty claims and cost to repair. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary. | ||||
Changes in the Company's warranty liability during the following period were as follows: | ||||
Three Months Ended | ||||
(in thousands) | July 27, 2014 | |||
Beginning balance at April 28, 2014 | $ | 5,744 | ||
Additions during the period based on product sold | 1,284 | |||
Change in estimates | (552 | ) | ||
Settlements and expirations | (807 | ) | ||
Ending balance at July 27, 2014 | $ | 5,669 | ||
Fair_Value_of_Financial_Instru
Fair Value of Financial Instruments | 3 Months Ended | |||||||||||||||||||||||||||||||||
Jul. 27, 2014 | ||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||||||||||||||||||||||
Fair Value of Financial Instruments | ' | |||||||||||||||||||||||||||||||||
Fair Value of Financial Instruments | ||||||||||||||||||||||||||||||||||
The Company's financial instruments measured at fair value on a recurring basis as of July 27, 2014 and April 27, 2014 were as follows: | ||||||||||||||||||||||||||||||||||
July 27, 2014 | April 27, 2014 | |||||||||||||||||||||||||||||||||
Carrying | Fair Value | Carrying | Fair Value | |||||||||||||||||||||||||||||||
(in thousands) | Amount | Level 1 | Level 2 | Level 3 | Total | Amount | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||
Money market funds | $ | 30,262 | $ | 30,262 | $ | — | $ | — | $ | 30,262 | $ | 30,169 | $ | 30,169 | $ | — | $ | — | $ | 30,169 | ||||||||||||||
Commercial paper | 89,927 | — | 89,927 | — | 89,927 | 89,922 | — | 89,922 | — | 89,922 | ||||||||||||||||||||||||
Certificates of deposit | 120,000 | — | 120,000 | — | 120,000 | 120,000 | — | 120,000 | — | 120,000 | ||||||||||||||||||||||||
Total | $ | 240,189 | $ | 30,262 | $ | 209,927 | $ | — | $ | 240,189 | $ | 240,091 | $ | 30,169 | $ | 209,922 | $ | — | $ | 240,091 | ||||||||||||||
The Company's Level 2 financial instruments in the table above are valued using quoted market prices for similar instruments or non-binding market prices that are corroborated by observable market data. | ||||||||||||||||||||||||||||||||||
The Company has not estimated the fair value of its minority investments in two privately held companies as it is not practicable to estimate the fair value of these investments because of the lack of quoted market prices and the inability to estimate fair value without incurring excessive costs. As of July 27, 2014, the carrying value of the Company's minority investments in these privately held companies was $2.3 million, which management believes is not impaired. | ||||||||||||||||||||||||||||||||||
The Company's financial instruments not measured at fair value on a recurring basis as of July 27, 2014 and April 27, 2014 were as follows: | ||||||||||||||||||||||||||||||||||
July 27, 2014 | April 27, 2014 | |||||||||||||||||||||||||||||||||
Carrying | Fair Value | Carrying | Fair Value | |||||||||||||||||||||||||||||||
(in thousands) | Amount | Level 1 | Level 2 | Level 3 | Total | Amount | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||
2029 Notes | $ | 40,015 | $ | 77,520 | $ | — | $ | — | $ | 77,520 | $ | 40,015 | $ | 104,105 | $ | — | $ | — | $ | 104,105 | ||||||||||||||
2033 Notes | 214,496 | 254,692 | — | — | 254,692 | 212,253 | 305,307 | — | — | 305,307 | ||||||||||||||||||||||||
Total | $ | 254,511 | $ | 332,212 | $ | — | $ | — | $ | 332,212 | $ | 252,268 | $ | 409,412 | $ | — | $ | — | $ | 409,412 | ||||||||||||||
The fair value of the 2029 Notes and 2033 Notes is based on the market price in the open market as of or close to the respective dates. The difference between the carrying value and the fair value is primarily due to the spread between the conversion price and the market value of the shares underlying the conversion. |
Stockholders_Equity
Stockholders' Equity | 3 Months Ended | |||||
Jul. 27, 2014 | ||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||
Stockholders' Equity | ' | |||||
Stockholders' Equity | ||||||
The number of shares of common stock issued or becoming vested under the Company's stock compensation plans was as follows: | ||||||
Three Months Ended | ||||||
July 27, 2014 | July 28, 2013 | |||||
Employee stock purchase plan | 291,589 | 340,657 | ||||
Exercises of stock options | 100,378 | 212,514 | ||||
Restricted stock units vesting | 1,854,873 | 1,360,789 | ||||
Pending_Litigation
Pending Litigation | 3 Months Ended |
Jul. 27, 2014 | |
Commitments and Contingencies Disclosure [Abstract] | ' |
Pending Litigation | ' |
The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and that it can reasonably estimate the amount of the loss. The Company reviews these accruals and adjusts them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel and other relevant information. To the extent new information is obtained and the Company's views on the probable outcomes of claims, suits, assessments, investigations or legal proceedings change, changes in the Company's accrued liabilities would be recorded in the period in which such determination is made. For the matters referenced below, the amount of liability is not probable or the amount cannot be reasonably estimated; and, therefore, accruals have not been made. In addition, in accordance with the relevant authoritative guidance, for matters which the likelihood of material loss is at least reasonably possible, the Company provides disclosure of the possible loss or range of loss; however, if a reasonable estimate cannot be made, the Company will provide disclosure to that effect. | |
Due to the nature of the Company's business, it is subject to claims alleging infringement by various Company products and services. The Company believes that it has meritorious defenses to the allegations made in its pending cases and intends to vigorously defend these lawsuits; however, it is unable currently to determine the ultimate outcome of these or similar matters. In addition, the Company is a defendant in various litigation matters generally arising out of the normal course of business. Although it is difficult to predict the ultimate outcomes of these cases, the Company believes that it is not reasonably possible that the ultimate outcomes will materially and adversely affect its business, financial position, results of operations or cash flows. | |
Class Action and Shareholder Derivative Litigation | |
Several securities class action lawsuits related to the Company's March 8, 2011 earnings announcement alleging claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 have been filed in the United States District Court for the Northern District of California on behalf of a purported class of persons who purchased stock between December 1 or 2, 2010 through March 8, 2011. The named defendants are the Company and its Chairman of the Board, Chief Executive Officer and Chief Financial Officer. To date, no specific amount of damages have been alleged. The cases were consolidated, lead plaintiffs were appointed and a consolidated complaint was filed. The Company filed a motion to dismiss the case. On January 16, 2013, the District Court granted the Company's motion to dismiss and granted the lead plaintiffs leave to amend the consolidated complaint. An amended consolidated complaint was filed on February 6, 2013. Thereafter, the Company filed a renewed motion to dismiss the case. On September 30, 2013, the District Court granted the Company's motion and dismissed the case with prejudice. On October 25, 2013, the lead plaintiffs filed a notice of appeal of the District Court's dismissal ruling, and the appeal is pending. | |
In addition, two purported shareholder derivative lawsuits related to the Company's March 8, 2011 earnings announcement have been filed in the California Superior Court for the County of Santa Clara, and a third derivative lawsuit has been filed in the United States District Court for the Northern District of California. The complaints assert claims for alleged breach of fiduciary duty, unjust enrichment, and waste on behalf of the Company. Named as defendants are the members of the Company's board of directors, including the Company's Chairman of the Board and Chief Executive Officer, and its Chief Financial Officer. No specific amount of damages has been alleged and, by the derivative nature of the lawsuits, no damages will be alleged, against the Company. The state court cases have been consolidated and a lead plaintiff has been appointed to file a consolidated complaint. The derivative cases were stayed pending a ruling in the federal class action case. Following the September 30 ruling dismissing the class action case, the derivative cases remain stayed, subject to the right of the parties to reinstate them. | |
Thomas Swan Litigation | |
On February 26, 2013, Thomas Swan & Co. Ltd. filed a complaint for patent infringement in the United States District Court for the Eastern District of Texas against the Company. The complaint alleges that Finisar's WSS products, ROADM line cards containing a Finisar WSS, and Waveshaper products infringe four related Thomas Swan patents. The Company's customer, Fujitsu Network Communications, has been added as a co-defendant in this lawsuit. The Company has performed a review of the asserted patents and believes that the patent claims are not infringed and/or are invalid. The Company intends to defend this lawsuit vigorously. However, there can be no assurance that the defense will be successful and, if the defense is not successful, Finisar may be liable for substantial damages, including possible indemnification obligations to the Company's customers. Even if the defense is successful, the Company may incur substantial legal fees and other costs in defending the lawsuit. Further, the lawsuit could divert the efforts and attention of the Company's management and technical personnel, which could harm its business. Trial in this case has been scheduled for February 2015. | |
Mears Technologies Litigation | |
On May 6, 2013, Mears Technologies, Inc. filed a complaint for patent infringement in the United States District Court for the Eastern District of Texas against the Company. The complaint alleges that Finisar's WSS products, ROADM line cards containing a Finisar WSS, and Waveshaper products infringe a Mears Technologies patent. The Company has performed an initial review of the asserted patent and believes that the patent claims are not infringed and/or are invalid. The Company intends to defend this lawsuit vigorously. However, there can be no assurance that the defense will be successful and, if the defense is not successful, Finisar may be liable for substantial damages, including possible indemnification obligations to the Company's customers. Even if the defense is successful, the Company may incur substantial legal fees and other costs in defending the lawsuit. Further, the lawsuit could divert the efforts and attention of the Company's management and technical personnel, which could harm its business. Trial in this case has been scheduled for December 2014. |
Guarantees_and_Indemnification
Guarantees and Indemnifications | 3 Months Ended |
Jul. 27, 2014 | |
Guarantees [Abstract] | ' |
Guarantees and Indemnifications | ' |
Guarantees and Indemnifications | |
Upon issuance of a guarantee, the guarantor must recognize a liability for the fair value of the obligations it assumes under that guarantee. As permitted under Delaware law and in accordance with the Company's Bylaws, the Company indemnifies its officers and directors for certain events or occurrences, subject to certain limits, while the officer or director is or was serving at the Company's request in such capacity. The term of the indemnification period is for the officer's or director's lifetime. The Company may terminate the indemnification agreements with its officers and directors upon 90 days written notice, but termination will not affect claims for indemnification relating to events occurring prior to the effective date of termination. The maximum amount of potential future indemnification is unlimited; however, the Company has a director and officer liability insurance policy that may enable it to recover a portion of any future amounts paid. | |
The Company enters into indemnification obligations under its agreements with other companies in its ordinary course of business, including agreements with customers, business partners and insurers. Under these provisions the Company generally indemnifies and holds harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of the Company's activities or the use of the Company's products. These indemnification provisions generally survive termination of the underlying agreement. In some cases, the maximum potential amount of future payments the Company could be required to make under these indemnification provisions is unlimited. | |
The Company believes the fair value of these indemnification obligations is immaterial. Accordingly, the Company has not recorded any liabilities for these agreements as of July 27, 2014. To date, the Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. |
Related_Party_Transaction
Related Party Transaction | 3 Months Ended |
Jul. 27, 2014 | |
Related Party Transactions [Abstract] | ' |
Related Parties | ' |
Related Parties | |
During the three month period ended July 27, 2014, the Company paid $41,532 in cash compensation to a company owned by Guy Gertel, the brother of the Chief Executive Officer of the Company, for sales and marketing services. In addition, during the first quarter of fiscal 2015, the Company granted to Mr. Gertel, for no additional consideration, 2,305 restricted stock units with a fair market value of $45,132, which vest as follows: 25% on June 23, 2015 and an additional 25% on each of the next three anniversaries thereafter, to be fully vested on June 23, 2018, subject to Mr. Gertel continuing to provide services to Finisar. | |
During the three month period ended July 28, 2013, the Company paid $55,572 in cash compensation to Mr. Gertel's company. In addition, during the first quarter of fiscal 2014, the Company granted to Mr. Gertel, for no additional consideration, 4,164 restricted stock units with a fair market value of $66,957, which vest as follows: 25% on June 24, 2014 and an additional 25% on each of the next three anniversaries thereafter, to be fully vested on June 24, 2017, subject to Mr. Gertel continuing to provide services to Finisar. | |
Amounts paid to Mr. Gertel represented values considered by management to be fair and reasonable, reflective of an arm's length transaction. |
Summary_of_Significant_Account1
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Jul. 27, 2014 | |
Accounting Policies [Abstract] | ' |
Consolidation, Policy | ' |
The accompanying unaudited condensed consolidated financial statements as of July 27, 2014 and for the three month periods ended July 27, 2014 and July 28, 2013 have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial statements and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”), and include the accounts of Finisar Corporation and its controlled subsidiaries (collectively, “Finisar” or the “Company”). Non-controlling interest represents the minority shareholders' proportionate share of the net assets and results of operations of the Company's majority-owned subsidiary, Finisar Korea, prior to its sale in the fourth quarter of fiscal 2014. Intercompany accounts and transactions have been eliminated in consolidation. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP and pursuant to the rules and regulations of the SEC have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of the Company's financial position as of July 27, 2014, its operating results for the three month periods ended July 27, 2014 and July 28, 2013, and its cash flows for the three month periods ended July 27, 2014 and July 28, 2013. | |
Use of Estimates, Policy | ' |
Use of Estimates | |
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates. | |
Segments, Policy | ' |
Segments | |
The Company has one reportable segment consisting of optical subsystems and components. | |
Earnings Per Share, Policy | ' |
Basic net income per share has been computed using the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share has been computed using the weighted-average number of shares of common stock and dilutive potential common shares from stock options and restricted stock units (under the treasury stock method), 5.0% Convertible Senior Notes due 2029 (on an as-if-converted basis), and 0.50% Convertible Senior Notes due 2033 (under the treasury stock method) outstanding during the period. | |
Standard Product Warranty, Policy | ' |
The Company generally offers a one-year limited warranty for its products. The specific terms and conditions of these warranties vary depending upon the product sold. The Company estimates the costs that may be incurred under its basic limited warranty and records a liability for the amount of such costs at the time revenue is recognized. Factors that affect the Company's warranty liability include the historical and anticipated rates of warranty claims and cost to repair. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary. |
Net_Income_per_Share_Tables
Net Income per Share (Tables) | 3 Months Ended | |||||||
Jul. 27, 2014 | ||||||||
Earnings Per Share [Abstract] | ' | |||||||
Schedule of Calculation of Numerator and Denominator in Earnings Per Share | ' | |||||||
The following table presents the calculation of basic and diluted net income per share: | ||||||||
Three Months Ended | ||||||||
(in thousands, except per share amounts) | July 27, 2014 | July 28, 2013 | ||||||
Numerator: | ||||||||
Net income attributable to Finisar Corporation | $ | 14,243 | $ | 26,011 | ||||
Numerator for basic net income per share | 14,243 | 26,011 | ||||||
Effect of dilutive securities: | ||||||||
Interest expense on 5.0% Convertible Senior Notes due 2029 | — | 539 | ||||||
Numerator for diluted net income per share | $ | 14,243 | $ | 26,550 | ||||
Denominator: | ||||||||
Denominator for basic net income per share - weighted average shares | 98,241 | 94,609 | ||||||
Effect of dilutive securities: | ||||||||
Stock options and restricted stock units | 4,046 | 2,768 | ||||||
5.0% Convertible Senior Notes due 2029 | — | 3,748 | ||||||
Dilutive potential common shares | 4,046 | 6,516 | ||||||
Denominator for diluted net income per share | 102,287 | 101,125 | ||||||
Net income per share attributable to Finisar Corporation common stockholders: | ||||||||
Basic | $ | 0.14 | $ | 0.27 | ||||
Diluted | $ | 0.14 | $ | 0.26 | ||||
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | ' | |||||||
The following table presents common shares related to potentially dilutive securities excluded from the calculation of diluted net income per share as their effect would have been anti-dilutive: | ||||||||
Three Months Ended | ||||||||
(in thousands) | July 27, 2014 | July 28, 2013 | ||||||
Stock options and restricted stock units | 627 | 2,537 | ||||||
5.0% Convertible Senior Notes due 2029 | 3,748 | — | ||||||
0.50% Convertible Senior Notes due 2033 (1) | — | — | ||||||
4,375 | 2,537 | |||||||
_______________ | ||||||||
(1) 0.50% Convertible Senior Notes due 2033 were excluded from the calculation of diluted earnings per share under the treasury stock method since the conversion price exceeded the average market price for the Company's common stock. |
Inventories_Tables
Inventories (Tables) | 3 Months Ended | |||||||
Jul. 27, 2014 | ||||||||
Inventory Disclosure [Abstract] | ' | |||||||
Schedule of Inventory, Current | ' | |||||||
Inventories consist of the following: | As of | |||||||
(in thousands) | July 27, 2014 | April 27, 2014 | ||||||
Raw materials | $ | 56,858 | $ | 52,594 | ||||
Work-in-process | 126,899 | 126,181 | ||||||
Finished goods | 86,365 | 80,984 | ||||||
Total inventories | $ | 270,122 | $ | 259,759 | ||||
Investments_Tables
Investments (Tables) | 3 Months Ended | |||||||||||||||||||||||||
Jul. 27, 2014 | ||||||||||||||||||||||||||
Investments [Abstract] | ' | |||||||||||||||||||||||||
Held-To-Maturity Securities | ' | |||||||||||||||||||||||||
The Company's investments in fixed income securities as of July 27, 2014 and April 27, 2014 were as follows: | ||||||||||||||||||||||||||
July 27, 2014 | April 27, 2014 | |||||||||||||||||||||||||
Gross Unrealized | Gross Unrealized | |||||||||||||||||||||||||
(in thousands) | Amortized Cost | Gains | Losses | Fair Value | Amortized Cost | Gains | Losses | Fair Value | ||||||||||||||||||
Commercial paper | $ | 89,927 | $ | — | $ | — | $ | 89,927 | $ | 89,922 | $ | — | $ | — | $ | 89,922 | ||||||||||
Certificates of deposit | 120,000 | — | — | 120,000 | 120,000 | — | — | 120,000 | ||||||||||||||||||
Total | $ | 209,927 | $ | — | $ | — | $ | 209,927 | $ | 209,922 | $ | — | $ | — | $ | 209,922 | ||||||||||
Reported as: | ||||||||||||||||||||||||||
Short-term investments | $ | 209,927 | $ | — | $ | — | $ | 209,927 | $ | 209,922 | $ | — | $ | — | $ | 209,922 | ||||||||||
Total | $ | 209,927 | $ | — | $ | — | $ | 209,927 | $ | 209,922 | $ | — | $ | — | $ | 209,922 | ||||||||||
Debt_Tables
Debt (Tables) | 3 Months Ended | |||
Jul. 27, 2014 | ||||
Debt Disclosure [Abstract] | ' | |||
Convertible Debt | ' | |||
The following table sets forth interest expense information related to the 2033 Notes: | ||||
Three Months Ended | ||||
(in thousands, except percentages) | July 27, 2014 | |||
Contractual interest expense | $ | 323 | ||
Amortization of the debt discount | 2,243 | |||
Amortization of issuance costs | 154 | |||
Total interest cost | $ | 2,720 | ||
Effective interest rate on the liability component | 4.87 | % | ||
he notes consisted of the following (in thousands): | ||||
Liability component: | ||||
Principal | $ | 258,750 | ||
Unamortized debt discount | (44,254 | ) | ||
Net carrying amount of the liability component | $ | 214,496 | ||
Carrying amount of the equity component | $ | 49,648 | ||
Warranty_Tables
Warranty (Tables) | 3 Months Ended | |||
Jul. 27, 2014 | ||||
Product Warranties Disclosures [Abstract] | ' | |||
Schedule of Product Warranty Liability | ' | |||
Changes in the Company's warranty liability during the following period were as follows: | ||||
Three Months Ended | ||||
(in thousands) | July 27, 2014 | |||
Beginning balance at April 28, 2014 | $ | 5,744 | ||
Additions during the period based on product sold | 1,284 | |||
Change in estimates | (552 | ) | ||
Settlements and expirations | (807 | ) | ||
Ending balance at July 27, 2014 | $ | 5,669 | ||
Fair_Value_of_Financial_Instru1
Fair Value of Financial Instruments (Tables) | 3 Months Ended | |||||||||||||||||||||||||||||||||
Jul. 27, 2014 | ||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||||||||||||||||||||||
Fair Value, Assets Measured on Recurring Basis | ' | |||||||||||||||||||||||||||||||||
The Company's financial instruments measured at fair value on a recurring basis as of July 27, 2014 and April 27, 2014 were as follows: | ||||||||||||||||||||||||||||||||||
July 27, 2014 | April 27, 2014 | |||||||||||||||||||||||||||||||||
Carrying | Fair Value | Carrying | Fair Value | |||||||||||||||||||||||||||||||
(in thousands) | Amount | Level 1 | Level 2 | Level 3 | Total | Amount | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||
Money market funds | $ | 30,262 | $ | 30,262 | $ | — | $ | — | $ | 30,262 | $ | 30,169 | $ | 30,169 | $ | — | $ | — | $ | 30,169 | ||||||||||||||
Commercial paper | 89,927 | — | 89,927 | — | 89,927 | 89,922 | — | 89,922 | — | 89,922 | ||||||||||||||||||||||||
Certificates of deposit | 120,000 | — | 120,000 | — | 120,000 | 120,000 | — | 120,000 | — | 120,000 | ||||||||||||||||||||||||
Total | $ | 240,189 | $ | 30,262 | $ | 209,927 | $ | — | $ | 240,189 | $ | 240,091 | $ | 30,169 | $ | 209,922 | $ | — | $ | 240,091 | ||||||||||||||
Fair Value, Liabilities Measured on Recurring Basis | ' | |||||||||||||||||||||||||||||||||
The Company's financial instruments not measured at fair value on a recurring basis as of July 27, 2014 and April 27, 2014 were as follows: | ||||||||||||||||||||||||||||||||||
July 27, 2014 | April 27, 2014 | |||||||||||||||||||||||||||||||||
Carrying | Fair Value | Carrying | Fair Value | |||||||||||||||||||||||||||||||
(in thousands) | Amount | Level 1 | Level 2 | Level 3 | Total | Amount | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||
2029 Notes | $ | 40,015 | $ | 77,520 | $ | — | $ | — | $ | 77,520 | $ | 40,015 | $ | 104,105 | $ | — | $ | — | $ | 104,105 | ||||||||||||||
2033 Notes | 214,496 | 254,692 | — | — | 254,692 | 212,253 | 305,307 | — | — | 305,307 | ||||||||||||||||||||||||
Total | $ | 254,511 | $ | 332,212 | $ | — | $ | — | $ | 332,212 | $ | 252,268 | $ | 409,412 | $ | — | $ | — | $ | 409,412 | ||||||||||||||
Stockholders_Equity_Tables
Stockholders' Equity (Tables) | 3 Months Ended | |||||
Jul. 27, 2014 | ||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||
Schedule of Common Stock Issued | ' | |||||
The number of shares of common stock issued or becoming vested under the Company's stock compensation plans was as follows: | ||||||
Three Months Ended | ||||||
July 27, 2014 | July 28, 2013 | |||||
Employee stock purchase plan | 291,589 | 340,657 | ||||
Exercises of stock options | 100,378 | 212,514 | ||||
Restricted stock units vesting | 1,854,873 | 1,360,789 | ||||
Basis_of_Presentation_Details
Basis of Presentation (Details) | 3 Months Ended |
Jul. 27, 2014 | |
Segments | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Number of reportable segments | 1 |
Net_Income_per_Share_Schedule_
Net Income per Share - Schedule of Calculation of Numerator and Denominator in Earnings Per Share (Details) (USD $) | 3 Months Ended | |
In Thousands, except Per Share data, unless otherwise specified | Jul. 27, 2014 | Jul. 28, 2013 |
Numerator: | ' | ' |
Net income (loss) attributable to Finisar Corporation (Numerator for basic net income per share) | $14,243 | $26,011 |
Effect of dilutive securities: | ' | ' |
Interest expense on 5.0% Convertible Senior Notes due 2029 | 0 | 539 |
Numerator for diluted net income per share | $14,243 | $26,550 |
Denominator: | ' | ' |
Denominator for basic net income per share - weighted average shares | 98,241 | 94,609 |
Effect of dilutive securities: | ' | ' |
Stock options and restricted stock units | 4,046 | 2,768 |
5.0% Convertible Senior Notes due 2029 | 0 | 3,748 |
Dilutive potential common shares | 4,046 | 6,516 |
Denominator for diluted net income per share | 102,287 | 101,125 |
Net income per share attributable to Finisar Corporation common stockholders: | ' | ' |
Basic (in dollars per share) | $0.14 | $0.27 |
Diluted (in dollars per share) | $0.14 | $0.26 |
Net_Income_per_Share_Schedule_1
Net Income per Share - Schedule of Antidilutive Securities Excluded from computation of Earnings Per Share (Details) | 3 Months Ended | ||||||||||||
In Thousands, unless otherwise specified | Jul. 27, 2014 | Jul. 28, 2013 | Jul. 27, 2014 | Jul. 28, 2013 | Jul. 27, 2014 | Jul. 28, 2013 | Jul. 27, 2014 | Jul. 28, 2013 | Jul. 27, 2014 | Jul. 27, 2014 | Dec. 31, 2013 | ||
Stock options and restricted stock units | Stock options and restricted stock units | 5.0% Convertible Senior Notes Due 2029 | 5.0% Convertible Senior Notes Due 2029 | 0.5% Convertible Senior Notes Due 2033 | 0.5% Convertible Senior Notes Due 2033 | Convertible Debt | Convertible Debt | Convertible Debt | |||||
Convertible Debt Securities [Member] | Convertible Debt Securities [Member] | Convertible Debt Securities [Member] | Convertible Debt Securities [Member] | 5.0% Convertible Senior Notes Due 2029 | 0.5% Convertible Senior Notes Due 2033 | 0.5% Convertible Senior Notes Due 2033 | |||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||
Interest Rate | ' | ' | ' | ' | ' | ' | ' | ' | 5.00% | 0.50% | 0.50% | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 4,375 | 2,537 | 627 | 2,537 | 3,748 | 0 | 0 | [1] | 0 | [1] | ' | ' | ' |
[1] | Convertible Senior Notes due 2033 were excluded from the calculation of diluted earnings per share under the treasury stock method since the conversion price exceeded the average market price for the Company's common stock. |
Inventories_Schedule_of_Invent
Inventories - Schedule of Inventory, Current (Details) (USD $) | Jul. 27, 2014 | Apr. 27, 2014 |
In Thousands, unless otherwise specified | ||
Inventory, Net [Abstract] | ' | ' |
Raw materials | $56,858 | $52,594 |
Work-in-process | 126,899 | 126,181 |
Finished goods | 86,365 | 80,984 |
Total inventories | $270,122 | $259,759 |
Investments_Details
Investments (Details) (USD $) | 3 Months Ended | ||
Jul. 27, 2014 | Jul. 28, 2013 | Apr. 27, 2014 | |
companies | companies | ||
Investment | ' | ' | ' |
Cost Method Investments | $884,000 | ' | $884,000 |
Cost Method Investment, Number of Companies | 1 | ' | 1 |
Equity Method Investments | 1,400,000 | ' | 1,200,000 |
Equity Method Investment, Number of Companies | 1 | ' | 0 |
Equity Method Investment, Ownership Percentage | 19.90% | ' | ' |
Realized Gain (Loss) on Marketable Securities, Cost Method Investments, and Other Investments | 0 | 0 | ' |
Other Nonoperating Income (Expense) | ' | ' | ' |
Investment | ' | ' | ' |
Income (Loss) from Equity Method Investments | $200,000 | $179,000 | ' |
Investments_HeldToMaturity_Sec
Investments - Held-To-Maturity Securities (Details) (USD $) | 3 Months Ended | ||
Jul. 27, 2014 | Jul. 28, 2013 | Apr. 27, 2014 | |
Investment | ' | ' | ' |
Realized Gain (Loss) on Marketable Securities, Cost Method Investments, and Other Investments | $0 | $0 | ' |
Amortized Cost | 209,927,000 | ' | 209,922,000 |
Gross Unrealized Gains | 0 | ' | 0 |
Gross Unrealized Losses | 0 | ' | 0 |
Fair Value | 209,927,000 | ' | 209,922,000 |
Short-term Investments | ' | ' | ' |
Investment | ' | ' | ' |
Amortized Cost | 209,927,000 | ' | 209,922,000 |
Gross Unrealized Gains | 0 | ' | 0 |
Gross Unrealized Losses | 0 | ' | 0 |
Fair Value | 209,927,000 | ' | 209,922,000 |
Commercial Paper | ' | ' | ' |
Investment | ' | ' | ' |
Amortized Cost | 89,927,000 | ' | 89,922,000 |
Gross Unrealized Gains | 0 | ' | 0 |
Gross Unrealized Losses | 0 | ' | 0 |
Fair Value | 89,927,000 | ' | 89,922,000 |
Certificates of Deposit | ' | ' | ' |
Investment | ' | ' | ' |
Amortized Cost | 120,000,000 | ' | 120,000,000 |
Gross Unrealized Gains | 0 | ' | 0 |
Gross Unrealized Losses | 0 | ' | 0 |
Fair Value | $120,000,000 | ' | $120,000,000 |
Debt_Details
Debt (Details) (USD $) | Jul. 27, 2014 | Apr. 27, 2014 | Jul. 27, 2014 | Dec. 31, 2013 | Jul. 27, 2014 | Jul. 27, 2014 | Jul. 27, 2014 |
Convertible Debt | Convertible Debt | Convertible Debt | Other Noncurrent Assets | Additional Paid-in Capital | |||
0.5% Convertible Senior Notes Due 2033 | 0.5% Convertible Senior Notes Due 2033 | 5.0% Convertible Senior Notes Due 2029 | Convertible Debt | Convertible Debt | |||
0.5% Convertible Senior Notes Due 2033 | 0.5% Convertible Senior Notes Due 2033 | ||||||
Debt Instrument | ' | ' | ' | ' | ' | ' | ' |
Principal | ' | ' | ' | $258,800,000 | ' | ' | ' |
Interest Rate | ' | ' | 0.50% | 0.50% | 5.00% | ' | ' |
Debt Instrument, Convertible, Conversion Price | ' | ' | ' | $30.18 | ' | ' | ' |
Debt Instrument Convertible Carrying Amount Of Liability Component | ' | ' | 209,100,000 | ' | ' | ' | ' |
Carrying Amount of Equity Component | ' | ' | 49,648,000 | ' | ' | ' | ' |
Debt Instrument, Convertible, Remaining Discount Amortization Period | ' | ' | '52 months | ' | ' | ' | ' |
Debt Issuance Cost | ' | ' | 3,800,000 | ' | ' | ' | ' |
Deferred Finance Costs, Noncurrent, Net | ' | ' | ' | ' | ' | 3,100,000 | ' |
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt | ' | ' | ' | ' | ' | ' | 725,000 |
Debt Instrument, Redemption Price, Percentage | ' | ' | ' | ' | 100.00% | ' | ' |
Current portion of convertible debt | $40,015,000 | $40,015,000 | ' | ' | $40,000,000 | ' | ' |
Debt_Liability_and_Equity_Comp
Debt - Liability and Equity Components of 0.50% Convertible Senior Notes Due 2033 (Details) (Convertible Debt, 0.5% Convertible Senior Notes Due 2033, USD $) | Jul. 27, 2014 |
In Thousands, unless otherwise specified | |
Convertible Debt | 0.5% Convertible Senior Notes Due 2033 | ' |
Carrying Amount | ' |
Principal | $258,750 |
Unamortized debt discount | -44,254 |
Net Carrying amount of the liability component | 214,496 |
Carrying Amount of Equity Component | $49,648 |
Debt_Debt_Interest_Expense_for
Debt Debt - Interest Expense for 0.50% Convertible Senior Notes Due 2033 (Details) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Jul. 27, 2014 | Jul. 28, 2013 |
Debt Instrument | ' | ' |
Amortization of Debt Discount (Premium) | $2,243 | $0 |
Convertible Debt | 0.5% Convertible Senior Notes Due 2033 | ' | ' |
Debt Instrument | ' | ' |
Interest Expense, Debt, Excluding Amortization | 323 | ' |
Amortization of Debt Discount (Premium) | 2,243 | ' |
Amortization of Financing Costs | 154 | ' |
Interest Expense, Debt | $2,720 | ' |
Debt Instrument, Interest Rate, Effective Percentage | 4.87% | ' |
Debt_Phantom_Detail
Debt - Phantom (Detail) (Convertible Debt, 0.5% Convertible Senior Notes Due 2033) | 1 Months Ended |
Dec. 31, 2013 | |
Debt Instrument | ' |
Debt Instrument, Convertible, Conversion Ratio | 0.0331301 |
Debt Instrument, Redemption, Period One | ' |
Debt Instrument | ' |
Debt Instrument, Redemption Price, Percentage | 100.00% |
Debt Instrument, Redemption, Period Two | ' |
Debt Instrument | ' |
Debt Instrument, Redemption Price, Percentage | 100.00% |
Debt Instrument, Redemption, Period Three | ' |
Debt Instrument | ' |
Debt Instrument, Redemption Price, Percentage | 100.00% |
Debt Instrument, Redemption, Period Four | ' |
Debt Instrument | ' |
Debt Instrument, Redemption Price, Percentage | 100.00% |
Debt Instrument, Redemption, Period Five | ' |
Debt Instrument | ' |
Debt Instrument, Redemption Price, Percentage | 100.00% |
Debt Instrument, Conversion, Option One | ' |
Debt Instrument | ' |
Debt Instrument, Convertible, Threshold Trading Days | 20 |
Debt Instrument, Convertible, Threshold Consecutive Trading Days | '30 days |
Convertible Debt, Conversion Price, Threshold Percentage, Minimum | 130.00% |
Debt Instrument, Conversion, Option Two | ' |
Debt Instrument | ' |
Debt Instrument, Convertible, Threshold Trading Days | 5 |
Debt Instrument, Convertible, Threshold Consecutive Trading Days | '5 days |
Convertible Debt, Conversion Price, Threshold Percentage, Minimum | 98.00% |
Warranty_Schedule_of_Product_W
Warranty - Schedule of Product Warranty Liability (Details) (USD $) | 3 Months Ended |
In Thousands, unless otherwise specified | Jul. 27, 2014 |
Movement in Standard Product Warranty Accrual [Roll Forward] | ' |
Beginning balance at April 28, 2014 | $5,744 |
Additions during the period based on product sold | 1,284 |
Change in estimates | -552 |
Settlements and expirations | -807 |
Ending balance at July 27, 2014 | $5,669 |
Fair_Value_of_Financial_Instru2
Fair Value of Financial Instruments - Fair Value of Assets Measured on a Recurring Basis (Details) (USD $) | Jul. 27, 2014 | Apr. 27, 2014 |
In Thousands, unless otherwise specified | companies | |
Financial Assets [Abstract] | ' | ' |
Minority Investments, Number of Companies | 2 | ' |
Minority investments | $2,317 | $2,117 |
Fair Value, Measurements, Recurring | Carrying Amount | ' | ' |
Financial Assets [Abstract] | ' | ' |
Total | 240,189 | 240,091 |
Fair Value, Measurements, Recurring | Carrying Amount | Money Market Funds | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | 30,262 | 30,169 |
Fair Value, Measurements, Recurring | Carrying Amount | Commercial Paper | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | 89,927 | 89,922 |
Fair Value, Measurements, Recurring | Carrying Amount | Certificates of Deposit | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | 120,000 | 120,000 |
Fair Value, Measurements, Recurring | Fair Value | ' | ' |
Financial Assets [Abstract] | ' | ' |
Total | 240,189 | 240,091 |
Fair Value, Measurements, Recurring | Fair Value | Money Market Funds | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | 30,262 | 30,169 |
Fair Value, Measurements, Recurring | Fair Value | Commercial Paper | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | 89,927 | 89,922 |
Fair Value, Measurements, Recurring | Fair Value | Certificates of Deposit | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | 120,000 | 120,000 |
Fair Value, Measurements, Recurring | Level 1 | Fair Value | ' | ' |
Financial Assets [Abstract] | ' | ' |
Total | 30,262 | 30,169 |
Fair Value, Measurements, Recurring | Level 1 | Fair Value | Money Market Funds | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | 30,262 | 30,169 |
Fair Value, Measurements, Recurring | Level 1 | Fair Value | Commercial Paper | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | 0 | 0 |
Fair Value, Measurements, Recurring | Level 1 | Fair Value | Certificates of Deposit | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | 0 | 0 |
Fair Value, Measurements, Recurring | Level 2 | Fair Value | ' | ' |
Financial Assets [Abstract] | ' | ' |
Total | 209,927 | 209,922 |
Fair Value, Measurements, Recurring | Level 2 | Fair Value | Money Market Funds | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | 0 | 0 |
Fair Value, Measurements, Recurring | Level 2 | Fair Value | Commercial Paper | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | 89,927 | 89,922 |
Fair Value, Measurements, Recurring | Level 2 | Fair Value | Certificates of Deposit | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | 120,000 | 120,000 |
Fair Value, Measurements, Recurring | Level 3 | Fair Value | ' | ' |
Financial Assets [Abstract] | ' | ' |
Total | 0 | 0 |
Fair Value, Measurements, Recurring | Level 3 | Fair Value | Money Market Funds | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | 0 | 0 |
Fair Value, Measurements, Recurring | Level 3 | Fair Value | Commercial Paper | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | 0 | 0 |
Fair Value, Measurements, Recurring | Level 3 | Fair Value | Certificates of Deposit | ' | ' |
Financial Assets [Abstract] | ' | ' |
Cash and Cash Equivalents, Fair Value Disclosure | $0 | $0 |
Fair_Value_of_Financial_Instru3
Fair Value of Financial Instruments - Fair Value of Liabilities Measured on a Recurring Basis (Details) (Fair Value, Measurements, Recurring, USD $) | Jul. 27, 2014 | Apr. 27, 2014 |
In Thousands, unless otherwise specified | ||
Carrying Amount | ' | ' |
Debt Instrument | ' | ' |
Total | $254,511 | $252,268 |
Carrying Amount | 2029 Notes | ' | ' |
Debt Instrument | ' | ' |
Convertible notes | 40,015 | 40,015 |
Carrying Amount | 2033 Notes | ' | ' |
Debt Instrument | ' | ' |
Convertible notes | 214,496 | 212,253 |
Fair Value | ' | ' |
Debt Instrument | ' | ' |
Total | 332,212 | 409,412 |
Fair Value | 2029 Notes | ' | ' |
Debt Instrument | ' | ' |
Convertible notes | 77,520 | 104,105 |
Fair Value | 2033 Notes | ' | ' |
Debt Instrument | ' | ' |
Convertible notes | 254,692 | 305,307 |
Level 1 | Fair Value | ' | ' |
Debt Instrument | ' | ' |
Total | 332,212 | 409,412 |
Level 1 | Fair Value | 2029 Notes | ' | ' |
Debt Instrument | ' | ' |
Convertible notes | 77,520 | 104,105 |
Level 1 | Fair Value | 2033 Notes | ' | ' |
Debt Instrument | ' | ' |
Convertible notes | 254,692 | 305,307 |
Level 2 | Fair Value | ' | ' |
Debt Instrument | ' | ' |
Total | 0 | 0 |
Level 2 | Fair Value | 2029 Notes | ' | ' |
Debt Instrument | ' | ' |
Convertible notes | 0 | 0 |
Level 2 | Fair Value | 2033 Notes | ' | ' |
Debt Instrument | ' | ' |
Convertible notes | 0 | 0 |
Level 3 | Fair Value | ' | ' |
Debt Instrument | ' | ' |
Total | 0 | 0 |
Level 3 | Fair Value | 2029 Notes | ' | ' |
Debt Instrument | ' | ' |
Convertible notes | 0 | 0 |
Level 3 | Fair Value | 2033 Notes | ' | ' |
Debt Instrument | ' | ' |
Convertible notes | $0 | $0 |
Stockholders_Equity_Schedule_o
Stockholders' Equity - Schedule of Common Stock Issued (Details) | 3 Months Ended | |
Jul. 27, 2014 | Jul. 28, 2013 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | ' |
Employee stock purchase plan | 291,589 | 340,657 |
Exercises of stock options | 100,378 | 212,514 |
Restricted stock units vesting | 1,854,873 | 1,360,789 |
Pending_Litigation_Details
Pending Litigation (Details) (Pending Litigation) | Mar. 08, 2011 | Feb. 26, 2013 |
Earnings Announcements Cases | Thomas Swan Litigation | |
lawsuit | patent | |
Loss Contingencies | ' | ' |
Loss Contingency, Pending Claims, Number | 2 | ' |
Loss Contingency, Patents Allegedly Infringed, Number | ' | 4 |
Guarantees_and_Indemnification1
Guarantees and Indemnifications (Details) | 3 Months Ended |
Jul. 27, 2014 | |
Guarantees [Abstract] | ' |
Indemnification, Period for Written Notice | '90 days |
Related_Party_Transaction_Deta
Related Party Transaction (Details) (Immediate Family Member of Management or Principle Owner, USD $) | 3 Months Ended | |||||||||
Jul. 27, 2014 | Jul. 28, 2013 | Jul. 27, 2014 | Jun. 14, 2013 | Jul. 27, 2014 | Jul. 28, 2013 | Jul. 27, 2014 | Jul. 28, 2013 | Jul. 27, 2014 | Jul. 28, 2013 | |
Share-based Compensation Award, Tranche One | Share-based Compensation Award, Tranche One | Share-based Compensation Award, Tranche Two | Share-based Compensation Award, Tranche Two | Share-based Compensation Award, Tranche Three | Share-based Compensation Award, Tranche Three | Share-based Compensation Award, Tranche Four | Share-based Compensation Award, Tranche Four | |||
Related Party Transaction | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Related party transaction expense | $41,532 | $55,572 | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds from Issuance of Restrcited Stock to Related Party | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' |
Related Party Transaction Restricted Stock Units Granted to Related Party | 2,305 | 4,164 | ' | ' | ' | ' | ' | ' | ' | ' |
Fair value of Restricted Stock Units granted to related party | $45,132 | $66,957 | ' | ' | ' | ' | ' | ' | ' | ' |
Related party transaction, vesting rate of Restricted Stock Units | ' | ' | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% |